After the Market Pullback, the Defensive Value of Two Blue-Chip Stocks Stands Out

Life Science, Technology

Riding on Strong Earnings and a $1.5 Billion Market Catalyst, Exelixis Is Poised for Takeoff

Life Science

CVS Stock Soars 107%: Steady Dividends Power Its Impressive Turnaround

Life Science

Is It Wise to Follow the Herd and Buy the Same Weight-Loss Drug Giant as the U.S. President?

Life Science

Billionaires Reduce Holdings in UnitedHealth, Yet Wall Street Remains Bullish

Life Science

Wall Street’s Big UNH Split: Berkshire Exits, Goldman Sees Solid Upside

Life Science

Teladoc Health’s Stock Plunges Over 90% as Market Questions Its Dominance

Life Science

Translating 10 Projects Weekly, Eli Lilly Launches Largest Acquisition Wave in Its History

Life Science

Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market

Life Science

Is Pfizer’s Stock, with a Dividend Yield Exceeding 6%, Undervalued by the Market?

Life Science

These Three Disruptive Stocks Are Poised to Deliver Massive Returns Over the Next Two Decades

Life Science, Technology

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

Life Science

Strong Performance in Healthcare Sector Driven by Multiple Positive Factors

Life Science

Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector

Life Science

Three Recession-Resistant Stocks Worth Investors’ Attention

Consumer Goods, Life Science